Topics

Clinical Trials About "teborg namn antibiotikaresistent bakterie" RSS

21:58 EST 17th February 2020 | BioPortfolio

We list hundreds of Clinical Trials about "teborg namn antibiotikaresistent bakterie" on BioPortfolio. We draw our references from global clinical trials data listed on ClinicalTrials.gov and refresh our database daily.

More Information about "teborg namn antibiotikaresistent bakterie" on BioPortfolio

We have published hundreds of teborg namn antibiotikaresistent bakterie news stories on BioPortfolio along with dozens of teborg namn antibiotikaresistent bakterie Clinical Trials and PubMed Articles about teborg namn antibiotikaresistent bakterie for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of teborg namn antibiotikaresistent bakterie Companies in our database. You can also find out about relevant teborg namn antibiotikaresistent bakterie Drugs and Medications on this site too.

Showing "teborg namn antibiotikaresistent bakterie" Clinical Trials, all 5

Relevant

PermeaDerm® vs. Mepilex-Ag® in Promoting Healing of Partial-thickness Burn Wounds

The purpose of this study is to compare the effectiveness of the wound dressings currently used at our institution for partial-thickness burn wounds: PermeaDerm® (PermeaDerm, Inc., Carlsbad, California, USA) and silver impregnated foam dressing (Mepilex Ag®, Health Care, Göteborg, Sweden)


Effects of a Clinical Pharmacist Service on Health-related Quality of Life

The aim of the present study is to evaluate effects of a clinical pharmacist service on health-related quality of life and prescribing of drugs. A randomized controlled trial is performed in two internal medicine wards at Sahlgrenska University Hospital, Göteborg, Sweden.

Probably Relevant

ALECSAT as Add on to Radiotherapy and TMZ in Patients With Newly Diagnosed Glioblastoma

This is a randomised, open-label, multi-centre, Phase II study in patients with newly diagnosed glioblastoma. Up to 87 patients with newly diagnosed glioblastoma will be enrolled in the study in a 1:2 allocation (SOC: ALECSAT as an adjunct therapy to SOC). Data from a further 29 patients gathered from an ongoing observational study of glioblastoma patients treated according to SOC at Sahlgrenska University hospital in Göteborg, Sweden will be used as historical control...


Implementation and Evaluation of RESCUR

This research program aims to investigate the implementation and effects of a theoretical promising prevention method developed in a European research collaboration within a Comenius project (2012-2015) between 6 European universities (in Malta, Italy, Greece, Croatia, Portugal and Sweden) with the purpose of enhancing European children's resilience. RESCUR in Sweden is a RCT study of the Resilience Curriculum (RESCUR) that is taking place in Sweden 2017-2019. The Swedish name...

CPS for Youth With Challenging Behavior

The method "Collaborative and Proactive Solutions" (CPS) was developed by Dr. Ross Greene, Harvard University, and provides a more compassionate and accurate way to understand and help kids with social, emotional, and behavioral challenges. The underlying theory is that challenging behavior is caused by lagging cognitive skills, commonly in the domains of flexibility/adaptability, frustration tolerance, and problem‐solving. Thus, challenging behavior can be seen as a form of ...


More From BioPortfolio on "teborg namn antibiotikaresistent bakterie"

Quick Search